v3.26.3
Revenue Recognition
9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three and nine months ended September 30, 2026 and 2025:
(thousands of U.S. dollars)Three Months Ended September 30, 2026
SterigenicsNordionNelson LabsConsolidated
Point in time$209,305 $52,113 $— $261,418 
Over time— 2,911 60,557 63,468 
Total$209,305 $55,024 $60,557 $324,886 
(thousands of U.S. dollars)Three Months Ended September 30, 2025
SterigenicsNordionNelson LabsConsolidated
Point in time$192,845 $61,308 $— $254,153 
Over time— 1,497 55,662 57,159 
Total$192,845 $62,805 $55,662 $311,312 
(thousands of U.S. dollars)Nine Months Ended September 30, 2026
SterigenicsNordionNelson LabsConsolidated
Point in time$607,011 $140,359 $— $747,370 
Over time— 5,823 173,113 178,936 
Total$607,011 $146,182 $173,113 $926,306 
(thousands of U.S. dollars)Nine Months Ended September 30, 2025
SterigenicsNordionNelson LabsConsolidated
Point in time$557,368 $134,979 $— $692,347 
Over time— 2,814 165,015 167,829 
Total$557,368 $137,793 $165,015 $860,176 
When we receive consideration from a customer prior to transferring goods or services under the terms of a sales contract, we record deferred revenue, which represents a contract liability. Deferred revenue totaled $15.1 million and $18.0 million at September 30, 2026 and December 31, 2025, respectively. We recognize deferred revenue after we have transferred control of the goods or services to the customer and all revenue recognition criteria are met.